Difficulty: Medium
Average Score: 70%
Practice
Which of the following antiretroviral drug combinations is accepted first-line therapy for patients with human immunodeficiency virus (HIV) infection?
Correct answer
B
Rationale
AZT + lamivudine + lopinavir/ritonavir (B) is an accepted first-line HIV therapy, combining two nucleoside reverse transcriptase inhibitors (NRTIs: AZT, lamivudine) with a boosted protease inhibitor (lopinavir/ritonavir), effectively suppressing viral replication and preventing resistance. AZT + ddC (A) lacks a third class, reducing efficacy. Ritonavir + amprenavir + enfuvirtide (C) mixes protease inhibitors and an entry inhibitor, not typical first-line. AZT + lamivudine + nevirapine (D), with an NNRTI, is viable but less common now versus integrase inhibitors. Modern guidelines favor integrase-based regimens (e.g., dolutegravir), but B reflects older, still-accepted triple therapy, balancing potency and resistance barriers.